These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 14505351)

  • 1. Effects of long-term administration of N-3 polyunsaturated fatty acids (PUFA) and selective estrogen receptor modulator (SERM) derivatives in ovariectomized (OVX) mice.
    Zeitlin L; Segev E; Fried A; Wientroub S
    J Cell Biochem; 2003 Oct; 90(2):347-60. PubMed ID: 14505351
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of SP500263, a novel selective estrogen receptor modulator, on bone, uterus, and serum cholesterol in the ovariectomized rat.
    Sutherland MK; Brady H; Gayo-Fung LM; Leisten J; Lipps SG; McKie JA; O'Leary E; Patnaik N; Anderson DW; Bhagwat SS; Stein B
    Calcif Tissue Int; 2003 Jun; 72(6):710-6. PubMed ID: 14563000
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of a selective estrogen receptor modulator on bone formation in osteoporotic spine fusion using an ovariectomized rat model.
    Park SB; Kim CH; Hong M; Yang HJ; Chung CK
    Spine J; 2016 Jan; 16(1):72-81. PubMed ID: 26343247
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Raloxifene inhibits adipose tissue inflammation and adipogenesis through Wnt regulation in ovariectomized rats and 3 T3-L1 cells.
    Shen HH; Yang CY; Kung CW; Chen SY; Wu HM; Cheng PY; Lam KK; Lee YM
    J Biomed Sci; 2019 Aug; 26(1):62. PubMed ID: 31470850
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LY353381.HCl: a novel raloxifene analog with improved SERM potency and efficacy in vivo.
    Sato M; Turner CH; Wang T; Adrian MD; Rowley E; Bryant HU
    J Pharmacol Exp Ther; 1998 Oct; 287(1):1-7. PubMed ID: 9765314
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dietary n-3 fatty acids decrease osteoclastogenesis and loss of bone mass in ovariectomized mice.
    Sun D; Krishnan A; Zaman K; Lawrence R; Bhattacharya A; Fernandes G
    J Bone Miner Res; 2003 Jul; 18(7):1206-16. PubMed ID: 12854830
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term dosing of arzoxifene lowers cholesterol, reduces bone turnover, and preserves bone quality in ovariectomized rats.
    Ma YL; Bryant HU; Zeng Q; Palkowitz A; Jee WS; Turner CH; Sato M
    J Bone Miner Res; 2002 Dec; 17(12):2256-64. PubMed ID: 12469920
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A new selective estrogen receptor modulator, CHF 4227.01, preserves bone mass and microarchitecture in ovariectomized rats.
    Armamento-Villareal R; Sheikh S; Nawaz A; Napoli N; Mueller C; Halstead LR; Brodt MD; Silva MJ; Galbiati E; Caruso PL; Civelli M; Civitelli R
    J Bone Miner Res; 2005 Dec; 20(12):2178-88. PubMed ID: 16294271
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Eicosapentaenoic acid, a n-3 polyunsaturated fatty acid differentially modulates TNF-alpha, IL-1alpha, IL-6 and PGE2 expression in UVB-irradiated human keratinocytes.
    Pupe A; Moison R; De Haes P; van Henegouwen GB; Rhodes L; Degreef H; Garmyn M
    J Invest Dermatol; 2002 Apr; 118(4):692-8. PubMed ID: 11918718
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective estrogen receptor modulator inhibits osteocyte apoptosis during abrupt estrogen withdrawal: implications for bone quality maintenance.
    Huber C; Collishaw S; Mosley JR; Reeve J; Noble BS
    Calcif Tissue Int; 2007 Aug; 81(2):139-44. PubMed ID: 17638036
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Raloxifene and estradiol benzoate both fully restore hippocampal choline acetyltransferase activity in ovariectomized rats.
    Wu X; Glinn MA; Ostrowski NL; Su Y; Ni B; Cole HW; Bryant HU; Paul SM
    Brain Res; 1999 Nov; 847(1):98-104. PubMed ID: 10564741
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of raloxifene-analog (LY 117018-Hcl) on the bone marrow of ovariectomized mice.
    Liu Z; Graff E; Benayahu D
    J Cell Biochem; 2000 Jan; 76(3):509-17. PubMed ID: 10649447
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of selective estrogen receptor modulator (SERM) activity in two triarylethylene oxybutyric acids.
    Rubin VN; Ruenitz PC; Boyd JL; Boudinot FD; Wiese TE
    Biochem Pharmacol; 2002 Apr; 63(8):1517-25. PubMed ID: 11996894
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interleukin-1 receptor antagonist and tumor necrosis factor binding protein decrease osteoclast formation and bone resorption in ovariectomized mice.
    Kitazawa R; Kimble RB; Vannice JL; Kung VT; Pacifici R
    J Clin Invest; 1994 Dec; 94(6):2397-406. PubMed ID: 7989596
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The selective estrogen receptor modulators (SERMs) raloxifene and tamoxifen improve ANP levels and decrease nuclear translocation of NF-kB in estrogen-deficient rats.
    Lamas AZ; Nascimento AM; Medeiros ARS; Caliman IF; Dalpiaz PLM; Firmes LB; Sousa GJ; Oliveira PWC; Andrade TU; Reis AM; Gouvea SA; Bissoli NS
    Pharmacol Rep; 2017 Aug; 69(4):798-805. PubMed ID: 28591668
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thyroid hormone contributes to the hypolipidemic effect of polyunsaturated fatty acids from fish oil: in vivo evidence for cross talking mechanisms.
    Souza LL; Cordeiro A; Oliveira LS; de Paula GS; Faustino LC; Ortiga-Carvalho TM; Oliveira KJ; Pazos-Moura CC
    J Endocrinol; 2011 Oct; 211(1):65-72. PubMed ID: 21752938
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of the selective estrogen receptor modulator ospemifene on bone in rats.
    Kangas L; Härkönen P; Väänänen K; Peng Z
    Horm Metab Res; 2014 Jan; 46(1):27-35. PubMed ID: 24108389
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-chain polyunsaturated fatty acids modulate lung inflammatory response induced by Pseudomonas aeruginosa in mice.
    Auvin S; Collet F; Gottrand F; Husson MO; Leroy X; Beermann C; Guery BP
    Pediatr Res; 2005 Aug; 58(2):211-5. PubMed ID: 16085793
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of 3-phenyl-4-[[4-[2-(1-piperidinyl)ethoxy]phenyl]methyl]- 2H-1-benzopyran-7-ol (CHF 4056), a novel nonsteroidal estrogen agonist/antagonist, on reproductive and nonreproductive tissue.
    Galbiati E; Caruso PL; Amari G; Armani E; Ghirardi S; Delcanale M; Civelli M
    J Pharmacol Exp Ther; 2002 Mar; 300(3):802-9. PubMed ID: 11861784
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lack of evidence for an increase in interleukin-6 expression in adult murine bone, bone marrow, and marrow stromal cell cultures after ovariectomy.
    Vargas SJ; Naprta A; Lee SK; Kalinowski J; Kawaguchi H; Pilbeam CC; Raisz LG; Lorenzo JA
    J Bone Miner Res; 1996 Dec; 11(12):1926-34. PubMed ID: 8970895
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.